Division of Molecular Medicine and Gene Therapy
21 – 30 of 575
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Unleashing Ascl1 : Exploring Cross-Lineage Potential in Reprogramming and Regenerative Frontiers
(
- Contribution to journal › Article
-
Mark
Engineered human Diamond-Blackfan anemia disease model confirms therapeutic effects of clinically applicable lentiviral vector at single-cell resolution
(
- Contribution to journal › Article
-
Mark
Combined GLUT1 and OXPHOS inhibition eliminates acute myeloid leukemia cells by restraining their metabolic plasticity
(
- Contribution to journal › Article
-
Mark
Restoring antitumor immunity with dendritic cell reprogramming strategies. Reprogramming cancer cells to antigen-presenting cells.
2023) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Reprogramming Stars #13 : Establishing Connections with Cellular Reprogramming–An Interview with Dr. Daniella Rylander Ottosson
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Mechanisms Underlying the Specification of Definitive Hematopoiesis
2023) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Recombinant α
1-Microglobulin (rA1M) Protects against Hematopoietic and Renal Toxicity, Alone and in Combination with Amino Acids, in a
177Lu-DOTATATE Mouse Radiation Model.
(
- Contribution to journal › Article
-
Mark
Ciclopirox Ethanolamine Preserves the Immature State of Human HSCs by Mediating Intracellular Iron Content
(
- Contribution to journal › Article
-
Mark
Challenging the definition of a blood group: Proposal to make CD36 a novel blood group system based on a case report and pre-existing genetic, proteomic and clinical data
(
- Contribution to journal › Published meeting abstract
-
Mark
Astrocyte dysfunction and neuronal network hyperactivity in a CRISPR engineered pluripotent stem cell model of frontotemporal dementia
(
- Contribution to journal › Article